Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.
Giuseppe LopalcoVincenzo VeneritoLuca CantariniGiacomo EmmiDomenico PriscoFlorenzo IannonePublished in: Internal and emergency medicine (2018)